🇺🇸 FDA

Company profile · Sponsor

Swedish

Swedish Orphan Biovitrum AB (publ)

E2BBB58 · EMA pharma Stockholm, SE
Pipeline
5
Drugs
0
Patents
0

Quick answer

Swedish (E2BBB58) is a pharma company. headquartered in Stockholm, SE. listed on EMA. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E2BBB58
Exchange EMA
Company type pharma
Headquarters Stockholm, SE

Pipeline (5)

Search pipeline →

  1. ALTUVOCT 2 000 IU powder and solvent for solution for injection, ALTUVOCT 3 000 IU powder and solvent for solution for injection, ALTUVOCT 4 000 IU powder and solvent for solution for injection, ALTUVOCT 250 IU powder and solvent for solution for injection, ALTUVOCT 1 000 IU powder and solvent for solution for injection, ALTUVOCT 500 IU powder and solvent for solution for injection

    Swedish

    Haemophilia A

    phase 3 small molecule active

    1 trial

  2. An Open-label, Single-arm, Multicenter Pilot Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Pegcetacoplan in Patients with Transplant-associated Thrombotic Microangiopathy (TA-TMA) After Hematopoietic Stem Cell Transplantation (HSCT)

    Swedish

    Transplant-associated Thrombotic Microangiopathy (TA TMA)

    phase 2 other active

    1 trial

  3. Pharmacokinetic comparison of efanesoctocog alfa vs other EHL-rFVIII products in participants with severe haemophilia A

    Swedish

    Haemophilia A

    phase 1 other active

    1 trial

  4. ALTUVOCT 250 IU powder and solvent for solution for injection, ALTUVOCT 3 000 IU powder and solvent for solution for injection, ALTUVOCT 500 IU powder and solvent for solution for injection, ALTUVOCT 2 000 IU powder and solvent for solution for injection, ALTUVOCT 1 000 IU powder and solvent for solution for injection, ALTUVOCT 4 000 IU powder and solvent for solution for injection

    Swedish

    Haemophilia A

    approved small molecule active

    1 trial

  5. ALTUVOCT 3 000 IU powder and solvent for solution for injection, ALTUVOCT 250 IU powder and solvent for solution for injection, ALTUVOCT 2 000 IU powder and solvent for solution for injection, ALTUVOCT 4 000 IU powder and solvent for solution for injection, ALTUVOCT 500 IU powder and solvent for solution for injection

    Swedish

    Haemophilia A

    approved small molecule active

    1 trial

Frequently asked questions

What is Swedish?

Swedish (E2BBB58) is a pharma company. headquartered in Stockholm, SE. listed on EMA. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Swedish sponsor?

We track 5 ClinicalTrials.gov-linked programs for Swedish, including ALTUVOCT 2 000 IU powder and solvent for solution for injection, ALTUVOCT 3 000 IU powder and solvent for solution for injection, ALTUVOCT 4 000 IU powder and solvent for solution for injection, ALTUVOCT 250 IU powder and solvent for solution for injection, ALTUVOCT 1 000 IU powder and solvent for solution for injection, ALTUVOCT 500 IU powder and solvent for solution for injection and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Swedish company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.